Alvotech Reiterates Meeting US Humira Biosimilar Launch Date

As Partner Cipla Bags Australian Approval For AVT02 Adalimumab Asset

 
• By Dean Rudge
  
FDA building.
Teva has commercialization rights in the US • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products